Missense mutations in the human insulin promoter factor-1 gene are not a common cause of Type 2 diabetes mellitus in Taiwan

Journal of Endocrinological Investigation

Volumn 27, Issue 11, 2004, Pages 1076-1080

  Shiau, Ming Yuh ^a,b   Huang, Chien Ning ^d   Liao, Jung Hua ^e   Chang, Yih Hsin ^c  

^a HUNGKUANG UNIVERSITY   (Taiwan)

^b Institutes of Medicine   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e SHOW CHWAN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

IPF 1; MODY; Type 2 diabetes mellitus

Indexed keywords

HOMEODOMAIN PROTEIN; INSULIN PROMOTER FACTOR 1; TRANSACTIVATOR PROTEIN;

AGED; ARTICLE; COHORT ANALYSIS; FEMALE; GENETIC VARIABILITY; GENETICS; HUMAN; MALE; MIDDLE AGED; MISSENSE MUTATION; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; TAIWAN;

AGE OF ONSET; AGED; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HOMEODOMAIN PROTEINS; HUMANS; MALE; MIDDLE AGED; MUTATION, MISSENSE; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; TAIWAN; TRANS-ACTIVATORS; VARIATION (GENETICS);

EID: 15744375067     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.1007/BF03345313     Document Type: Note

References (25)

1. Tattersall RB, Fajans SS. A difference between the inheritance of classical juvenile-onset and maturity-onset type diabetes of young people. Diabetes 1975, 24: 44-53.
2. Yamagata K, Furuta H, Oda O, et al. Mutations in the hepatocyte nuclear factor 4 alpha gene in maturity-onset diabetes of the young (MODY1). Nature 1996, 384:458-60.
3. Froguel P, Zouali H, Vionnet N, et al. Familial hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus. N Eng J Med 1993, 328: 697-702.
4. Yamagata K, Oda N, Kaisaki PJ, et al. Mutations in the hepatocyte nuclear factor 1 alpha gene in maturity-onset diabetes of the young (MODY3). Nature 1996, 384: 455-8.
5. Stoffers DA, Ferrer J, Clarke WL, Habener JF. Early-onset type 2 diabetes mellitus (MODY4) linked to IPF1. Nat Genet 1997, 17: 138-9.
6. Horikawa Y, Iwasaki N, Hara M, et al. Mutation in the hepatocyte nuclear factor-1 β gene (TCF2) associated with MODY. Nat Genet 1997, 17: 384-5.
7. Malecki MT, Jhala US, Antonellis A, et al. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet 1999, 23: 323-8.
8. Shimomura H, Sanke T, Hanabusa T, Tsunoda K, Furuta H, Nanjo K. Nonsense mutation of Islet-1 gene (Q310X) found in a type 2 diabetic patient with a strong family history. Diabetes 2000, 49: 1597-600.
9. Ohlsson H, Karlsson K, Edlund T. IPF1, a homeodomain-containing transactivator of the insulin gene. EMBO J 1993, 12: 4251-9.
10. Jonsson JL, Carlsson L, Edlund T, Edlund H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 1994, 371: 606-9.
11. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet 1997, 15: 106-10.
12. Melloul D, Ben-Neriah Y, Cerasi E. Glucose modulates the binding of an islet-specific factor to a conserved sequence within the rat I and the human insulin promoters. Proc Natl Acad Sci U S A 1993, 90: 3865-9.
13. Macfarlane W, Read ML, Gilligan M, Bujalska I, Docherty K. Glucose modulates the binding activity of the β cell transcription factor IPF-1 in a phosphorylation-dependentmanner. Biochem J 1994, 303: 625-31.
14. Marshak S, Totary H, Cerasi E, Melloul D. Purification of the β-cell glucose-sensitive factor that transactivates the insulin gene dif ferentially in normal and transformed islet cells. Proc Natl Acad Sci U S A 1996, 93: 15057-62.
15. Clocquet AR, Egan JM, Stoffers DA, et al. Impaired insulin secretion and increased insulin sensitivity in familial maturity-onset diabetes of the young 4 (Insulin Promoter Factor 1 Gene). Diabetes 2000, 49: 1856-64.
16. Macfarlane WM, Frayling TM, Ellard S, et al. Missense mutations in the insulin promoter factor-1 gene predispose to type 2 diabetes. J Clin Invest 1999, 104: R33-9.
17. Hani EH, Stoffers DA, Chevre JC, et al. Defective mutations in the insulin promoter factor-1 (IPF-1) gene in late-onset type 2 diabetes mellitus. J Clin Invest 1999, 104: R41-8.
18. Inoue H, Riggs AC, Tanizawa Y, et al. Isolation, characterization, and chromosomal mapping of the human insulin promoter factor 1 (IPF-1) gene. Diabetes 1996, 45: 789-94.
19. Hara M, Lindner TH, Paz VP, et al. Mutations in the codingregion of the insulin promoter factor 1 gene are not a common cause of maturity-onset diabetes of the young in Japanese subjects. Diabetes 1998, 47: 845-6.
20. Baier LJ, Permana PA, Traurig M, et al. Mutations in the genes for hepatocyte nuclear factor (HNF)-1α, -4α, -1β, and -3β; the dimerization cofactor of HNF-1; and insulin promoter factor 1 are not common causes of early-onset type 2 diabetes in Pima Indians. Diabetes Care 2000, 23: 302-4.
21. Reis AF, Ye WZ, Dubois-Laforgue D, Bellanne-Chantelot C, Timsit J, Velho G. Mutations in the insulin promoter factor-1 gene in late-onset type 2 diabetes mellitus. Eur J Endocrinol 2000, 143:511-3.
22. Hansen L, Urioste S, Petersen HV, et al. Missense mutations in the human insulin promoter factor-1 gene and their relation to maturity-onset diabetes of the young and late-onset type 2 diabetes mellitus in Caucasians. J Clin Endocrinol Metab 2000, 85: 1323-6.
23. Weng J, Macfarlane WM, Lehto M, et al. Functional consequences of mutations in the MODY4 gene (IPF1) and coexistence with MODY3 mutations. Diabetologia 2001, 44: 249-58.
24. Chevre JC, Hani EH, Stoffers DA, Habener JF, Froguel P. Insulin promoter factor 1 gene is not a major cause of maturity-onset diabetes of the young in French Caucasians. Diabetes 1998, 47: 843-4.
25. Dutta S, Bonner-Weir S, Montminy M, Wright C. Regulatory factor linked to late-onset diabetes? Nature 1998, 392: 560.